Qinsong Sheng
Qinsong Sheng publishes mostly in Oncology, Surgery and Molecular Biology, on topics such as Colorectal Cancer Surgical Treatments, Cancer Immunotherapy and Biomarkers and Gut microbiota and health.
- World rank
- #1,981,498 of 7,710,434 ranked researchers
- Rank in China
- #304,652 of 978,568
- Works
- 41
- Citations
- 1.3k
- Citations per work
- 30.9
What does Qinsong Sheng research?
Qinsong Sheng's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2254.7%
- Medicine2254.7%
- Everything else1435.0%
- Life Sciences410.3%
- 1Oncology21% of their works
- 2Surgery18% of their works
- 3Molecular Biology10% of their works
- 4Pathology and Forensic Medicine7% of their works
- 5Epidemiology4% of their works
- 6Infectious Diseases4% of their works
Research topics
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Gut microbiota and health
- Genetic factors in colorectal cancer
- Multiple and Secondary Primary Cancers
- Gastrointestinal Tumor Research and Treatment
- Clostridium difficile and Clostridium perfringens research
- Colorectal Cancer Treatments and Studies
Which keywords describe Qinsong Sheng's research?
The keywords of their largest research topics: Adjuvant Chemotherapy, Clinical Practice Guidelines, Preoperative Chemoradiotherapy, Rectal Cancer, Immune Checkpoint Blockade, PD-1 and PD-L1, Gut Microbiota and Microbial Communities.
- Sunitinib
- Multiple Primary Cancers
- Imatinib Mesylate
- Cetuximab
- Molecular Characterization
- Microbial Communities
- PD-1 and PD-L1
- Rectal Cancer
- Clinical Practice Guidelines
- Adjuvant Chemotherapy
- Preoperative Chemoradiotherapy
- Immune Checkpoint Blockade
- Gut Microbiota
- Microsatellite Instability
- Antibiotic-Associated Diarrhea
- Fecal Microbiota Transplantation
- KRAS Mutations
- Second Primary Neoplasms
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Adjuvant Chemotherapy132 topics
- Clinical Practice Guidelines122 topics
- Preoperative Chemoradiotherapy91 topic
- Rectal Cancer91 topic
- Immune Checkpoint Blockade51 topic
- PD-1 and PD-L151 topic
- Gut Microbiota41 topic
- Microbial Communities41 topic
- Microsatellite Instability41 topic
- Molecular Characterization41 topic
- Antibiotic-Associated Diarrhea31 topic
- Cetuximab31 topic
- Fecal Microbiota Transplantation31 topic
- Imatinib Mesylate31 topic
- KRAS Mutations31 topic
- Multiple Primary Cancers31 topic
- Second Primary Neoplasms31 topic
- Sunitinib31 topic
Where does Qinsong Sheng work?
Qinsong Sheng's main affiliation in the publication record is Zhejiang University, China.
How many publications and citations does Qinsong Sheng have?
OpenAlex counts 41 works and 1,268 citations for Qinsong Sheng, an h-index of 17, ranking #1,981,498 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Qinsong Sheng. Posts are plain text and can be reported.